Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Chappell

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Cell Science|June 1, 1995
gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complexS Stefansson, M Z Kounnas, J Henkin, et al.
The New England Journal of Medicine|June 15, 1989
Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46)S G Young, S T Hubl, D A Chappell, et al.
Annals of the New York Academy of Sciences|September 10, 1994
The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptorD A Chappell, I Inoue, G L Fry, et al.
The Journal of Biological Chemistry|September 16, 1994
The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptorF D Battey, M E Gåfvels, D J FitzGerald, et al.
The Journal of Biological Chemistry|July 5, 1993
Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycansD A Chappell, G L Fry, M A Waknitz, et al.
JAMA|February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathyC M Mendel, R F Klein, D A Chappell, et al.
The Journal of Biological Chemistry|July 8, 1994
Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipaseD A Chappell, I Inoue, G L Fry, et al.
The Journal of Biological Chemistry|July 19, 1996
Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitroJ D Medh, S L Bowen, G L Fry, et al.
The Journal of Biological Chemistry|March 25, 1994
The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRPS E Williams, I Inoue, H Tran, et al.
The Journal of Biological Chemistry|November 3, 1995
The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexesK M Argraves, F D Battey, C D MacCalman, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cell Science|June 1, 1995
gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complexS Stefansson, M Z Kounnas, J Henkin, et al.
The New England Journal of Medicine|June 15, 1989
Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46)S G Young, S T Hubl, D A Chappell, et al.
Annals of the New York Academy of Sciences|September 10, 1994
The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptorD A Chappell, I Inoue, G L Fry, et al.
The Journal of Biological Chemistry|September 16, 1994
The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptorF D Battey, M E Gåfvels, D J FitzGerald, et al.
The Journal of Biological Chemistry|July 5, 1993
Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycansD A Chappell, G L Fry, M A Waknitz, et al.
JAMA|February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathyC M Mendel, R F Klein, D A Chappell, et al.
The Journal of Biological Chemistry|July 8, 1994
Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipaseD A Chappell, I Inoue, G L Fry, et al.
The Journal of Biological Chemistry|July 19, 1996
Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitroJ D Medh, S L Bowen, G L Fry, et al.
The Journal of Biological Chemistry|March 25, 1994
The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRPS E Williams, I Inoue, H Tran, et al.
The Journal of Biological Chemistry|November 3, 1995
The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexesK M Argraves, F D Battey, C D MacCalman, et al.
Pageof 5